2026-10-20 12:00:00 UTC#486332newconfirmednews
Revvity (RVTY) stock news
Revvity (RVTY) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-09 16:20:16 UTC#439532newconfirmednews
Revvity, Inc. average analyst price target raised to $142.93, implying 6% downside
2026-09-24 12:00:00 UTC#362277newconfirmednews
Revvity launches CE-IVDR certified GSP T1D 3plex screening kit in Europe
tradingviewimportance 0.40trust 0.70Revvity, Inc. +0.40Sanofi +0.30GSP T1D 3plex kit +0.40+1 entities
2026-09-22 08:19:00 UTC#347262newconfirmednews
Global High Content Screening Market Projected to Reach $2.2 Billion by 2030, 9.2% CAGR
yahooimportance 0.30trust 0.50Thermo Fisher Scientific Inc. +0.20Danaher Corporation +0.20Revvity, Inc. +0.20+2 entities
2026-09-22 08:17:00 UTC#347261newconfirmednews
Global High Throughput Screening Market Forecasted to Reach $45.3 Billion by 2030, 0.9% CAGR
yahooimportance 0.30trust 0.50Thermo Fisher Scientific Inc. +0.10Agilent Technologies, Inc. +0.10Danaher Corporation +0.10+2 entities
2026-09-18 16:21:16 UTC#334713newconfirmednews
Revvity downgraded to Hold at CFRA on limited near-term upside potential
2026-09-15 20:15:43 UTC#316662newconfirmednews
Revvity shares climb 9% to reach new record high
2026-09-14 13:23:23 UTC#307623newconfirmedanalysis
Revvity (RVTY) pivots to AI-integrated life sciences and software-driven growth model
2026-09-09 10:48:49 UTC#285825newconfirmednews
Revvity announces acquisition of Human Cell Design
2026-09-04 13:27:00 UTC#268553newconfirmednews
KeyBanc raises Revvity (RVTY) price target to $165 from $125
2026-09-01 12:13:00 UTC#248895newconfirmednews
RBC Capital initiates coverage of Revvity (RVTY) at Sector Perform
2026-08-05 15:39:00 UTC#131046newconfirmednews
Evercore ISI Group maintains Revvity at Outperform, raises price target to $126 from $125
2026-08-04 18:51:04 UTC#125008updateconfirmednews
Revvity targets 2026 organic growth of 4-5% and adjusted EPS of $5.30-$5.40
2026-08-04 13:29:26 UTC#123529duplicateconfirmednews
Revvity Q2 2026 Adjusted EPS $1.41 Beats Estimates; FY26 Outlook Raised on Diagnostics and AI Demand
2026-08-04 12:51:36 UTC#123113updateconfirmednews
Revvity raises FY26 outlook for growth and EPS following Q2 beat driven by diagnostics and AI demand
2026-08-04 10:12:21 UTC#121977updateconfirmednews
Revvity beats Q2 earnings and revenue estimates, updates FY26 financial outlook
2026-08-04 10:01:00 UTC#121879duplicateconfirmednews
Revvity Reports Q2 EPS of 47 Cents
2026-08-04 10:01:00 UTC#121878updateconfirmednews
Revvity reports Q2 EPS from continuing operations of 48 cents
2026-08-04 10:00:00 UTC#122073duplicateconfirmedpress release
Revvity Reports Q2 2026 Adj. EPS $1.41, Revenue $730M and Announces Divestiture of China Immunodiagnostics
2026-08-04 10:00:00 UTC#122070duplicateconfirmednews